COVID-19 vaccine efficacy against variants

Note: In US trials. Average of 66% efficacy with South Africa and Latin America trials included.

Source: CDC; Science; LA Times; BMJ; UW Medicine; Reuters; Lancet; Lancet Preprint; Biorxiv; Moderna; Nature; New England Journal of Medicine; Imperial College London; CoV-lineages.org; Reuters; The Conversation; MMWR; biorxiv; The Guardian; Hindustan Times; The WHO; NEJM